Skip to main content
Oncology

Running for Research: A Live Report From the 2025 AACR Philadelphia Marathon Weekend

Steve Schneible covered the AACR Philadelphia Marathon Weekend live, including updates from his own participation…
Neurology

<![CDATA[Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results]]>

Post Content: Source: Neurology Read More
Neurology

<![CDATA[Analyzing Subgroup Data From the TRAILBLAZER-ALZ 2 Study of Donanemab: Brandy Matthews, MD]]>

Post Content: Source: Neurology Read More
Neurology
<![CDATA[Newly Launched Phase POLARIS-AD Trial Tests Oral Therapy AR1001 for Early Alzheimer Disease]]>
Neurology
<![CDATA[Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease]]>
Neurology
<![CDATA[Brainstorming Ways of Improving Representation Across Alzheimer Disease Clinical Research: Sid O’Bryant, PhD]]>
Neurology
<![CDATA[NF1-PN Treatment Goals and Quality of Life Impact]]>
Neurology
<![CDATA[NF1 Diagnostic Criteria and Clinical Recognition]]>
Neurology
<![CDATA[CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease]]>
admin
By In Pyschiatry

What APA Is Doing for You: Update on Clozapine REMS

In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
Visit Our Podcast

Oncology Overdrive